CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an email to The N&O, a company spokesperson said its mRNA programs cited by HHS aren’t active and thus “this decision has no impact on our research.”

This was one in a continuing line of moves that have put Kennedy's vaccine skepticism into public policy, though scientists say the vaccines are safe.